bioMérieux Partners in Ambitious Initiative to Promote the Value of Innovative Diagnostic Tests in Battling Antibiotic Resistance
The University of Antwerp has announced the creation of an Innovative Medicines Initiative (IMI) called VALUE-Dx, in partnership with bioMérieux and Wellcome Trust. According to the University of Antwerp, “The purpose of VALUE-Dx is to transform medical practice to achieve more personalized, evidence-based antibiotic prescription and use in community care settings through the widespread use of clinical and cost-effective innovative diagnostic strategies.”
Advancing data technologies to corner AMR 2019
International Matchmaking Symposium on 5 June, 2019 in Amsterdam, The Netherlands.
Artificial Intelligence, Internet-of-Things and Blockchain to stop ever-escalating Antimicrobial resistance.